110 related articles for article (PubMed ID: 3510654)
1. Cutaneous immunological studies in diagnosis of acute graft-versus-host disease.
Dreno B; Milpied N; Harousseau JL; Stalder JF; Bureau B; Milpied B; Barriere H
Br J Dermatol; 1986 Jan; 114(1):7-15. PubMed ID: 3510654
[TBL] [Abstract][Full Text] [Related]
2. Immunologic aspects of acute cutaneous graft-versus-host disease: decreased density and antigen-presenting function of Ia+ Langerhans cells and absent antigen-presenting capacity of Ia+ keratinocytes.
Breathnach SM; Shimada S; Kovac Z; Katz SI
J Invest Dermatol; 1986 Mar; 86(3):226-34. PubMed ID: 2427602
[TBL] [Abstract][Full Text] [Related]
3. Epithelial class II antigen expression in cutaneous graft-versus-host disease.
Beschorner WE; Farmer ER; Saral R; Stirling WL; Santos GW
Transplantation; 1987 Aug; 44(2):237-43. PubMed ID: 3307048
[TBL] [Abstract][Full Text] [Related]
4. Immunological analysis of the skin in graft versus host disease.
Lampert IA; Janossy G; Suitters AJ; Bofill M; Palmer S; Gordon-Smith E; Prentice HG; Thomas JA
Clin Exp Immunol; 1982 Oct; 50(1):123-31. PubMed ID: 6756725
[TBL] [Abstract][Full Text] [Related]
5. Sequential immunohistologic analysis of the skin following allogeneic bone marrow transplantation.
Volc-Platzer B; Rappersberger K; Mosberger I; Hinterberger W; Emminger-Schmidmeier W; Radaszkiewicz T; Wolff K
J Invest Dermatol; 1988 Aug; 91(2):162-8. PubMed ID: 3294303
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemistry of cutaneous graft-versus-host disease after allogeneic bone marrow transplantation.
Girolomoni G; Pincelli C; Zambruno G; Andreani M; Giardini C; Lucarelli G; Giannetti A
J Dermatol; 1991 Jun; 18(6):314-23. PubMed ID: 1939860
[TBL] [Abstract][Full Text] [Related]
7. A sequential study of histological and immunological changes in the skin after allogenic bone marrow transplantation.
Guyotat D; Mauduit G; Chouvet B; Kanitakis J; Van HV; Fiere D; Thivolet J
Transplantation; 1986 Mar; 41(3):340-2. PubMed ID: 3082048
[TBL] [Abstract][Full Text] [Related]
8. LN-3: a diagnostic adjunct in cutaneous graft-versus-host disease.
Synovec MS; Braddock SW; Jones J; Linder J
Mod Pathol; 1990 Nov; 3(6):643-7. PubMed ID: 1702211
[TBL] [Abstract][Full Text] [Related]
9. Morphological and immunohistological changes in the skin in allogeneic bone marrow recipients.
Sloane JP; Thomas JA; Imrie SF; Easton DF; Powles RL
J Clin Pathol; 1984 Aug; 37(8):919-30. PubMed ID: 6381547
[TBL] [Abstract][Full Text] [Related]
10. Keratinocytes synthesize Ia antigen in acute cutaneous graft-vs-host disease.
Breathnach SM; Katz SI
J Immunol; 1983 Dec; 131(6):2741-5. PubMed ID: 6417231
[TBL] [Abstract][Full Text] [Related]
11. Expression of MHC class I and II antigens by keratinocytes and enterocytes in acute graft-versus-host disease. Newcastle Bone Marrow Transplant Group.
Sviland L; Pearson AD; Green MA; Eastham EJ; Malcolm AJ; Proctor SJ; Hamilton PJ
Bone Marrow Transplant; 1989 May; 4(3):233-8. PubMed ID: 2659108
[TBL] [Abstract][Full Text] [Related]
12. A prospective study of the histological changes in the skin in patients receiving bone marrow transplants.
Lever R; Turbitt M; Mackie R; Hann I; Gibson B; Burnett A; Willoughby M
Br J Dermatol; 1986 Feb; 114(2):161-70. PubMed ID: 2936371
[TBL] [Abstract][Full Text] [Related]
13. Current understanding of the aetiology and clinical implications of cutaneous graft-versus-host disease.
Breathnach SM
Br J Dermatol; 1986 Feb; 114(2):139-43. PubMed ID: 3511941
[No Abstract] [Full Text] [Related]
14. Primary human keratinocytes as targets in predicting acute graft-versus-host disease following HLA-identical bone marrow transplantation.
van Dijk AM; Kessler FL; Verdonck LF; Stadhouders-Keet SA; van Lier RA; de Gast GC; Otten HG
Br J Haematol; 2000 Dec; 111(3):791-6. PubMed ID: 11122139
[TBL] [Abstract][Full Text] [Related]
15. Evidence of HLA-DR antigen biosynthesis by human keratinocytes in disease.
Volc-Platzer B; Majdic O; Knapp W; Wolff K; Hinterberger W; Lechner K; Stingl G
J Exp Med; 1984 Jun; 159(6):1784-9. PubMed ID: 6202820
[TBL] [Abstract][Full Text] [Related]
16. Detection of HLA restricted anti-minor histocompatibility antigen(s) reactive cells from skin GVHD lesions.
Reinsmoen NL; Kersey JH; Bach FH
Hum Immunol; 1984 Dec; 11(4):249-57. PubMed ID: 6392220
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical study of graft-versus-host reaction (GVHR)-type drug eruptions.
Osawa J; Kitamura K; Saito S; Ikezawa Z; Nakajima H
J Dermatol; 1994 Jan; 21(1):25-30. PubMed ID: 7908910
[TBL] [Abstract][Full Text] [Related]
18. Mononuclear cell subpopulations in the skin defined by monoclonal antibodies after HLA-identical sibling marrow transplantation.
Atkinson K; Munro V; Vasak E; Biggs J
Br J Dermatol; 1986 Feb; 114(2):145-60. PubMed ID: 3511942
[TBL] [Abstract][Full Text] [Related]
19. Murine sclerodermatous graft-versus-host disease, a model for human scleroderma: cutaneous cytokines, chemokines, and immune cell activation.
Zhang Y; McCormick LL; Desai SR; Wu C; Gilliam AC
J Immunol; 2002 Mar; 168(6):3088-98. PubMed ID: 11884483
[TBL] [Abstract][Full Text] [Related]
20. Immunopathology of cutaneous graft-versus-host disease.
Breathnach SM; Katz SI
Am J Dermatopathol; 1987 Aug; 9(4):343-8. PubMed ID: 2443033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
